BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 17878286)

  • 1. Ectopic expression of porcine peroxisome proliferator-activated receptor delta regulates adipogenesis in mouse myoblasts.
    Yu YH; Wu SC; Cheng WT; Mersmann HJ; Ding ST
    J Anim Sci; 2008 Jan; 86(1):64-72. PubMed ID: 17878286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Porcine peroxisome proliferator-activated receptor gamma induces transdifferentiation of myocytes into adipocytes.
    Yu YH; Liu BH; Mersmann HJ; Ding ST
    J Anim Sci; 2006 Oct; 84(10):2655-65. PubMed ID: 16971566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Docosahexaenoic acid regulates adipogenic genes in myoblasts via porcine peroxisome proliferator-activated receptor gamma.
    Yu YH; Lin EC; Wu SC; Cheng WT; Mersmann HJ; Wang PH; Ding ST
    J Anim Sci; 2008 Dec; 86(12):3385-92. PubMed ID: 18676720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of peroxisome proliferator-activated receptor beta/delta in chicken adipogenesis.
    Sato K; Yonemura T; Ishii H; Toyomizu M; Kamada T; Akiba Y
    Comp Biochem Physiol A Mol Integr Physiol; 2009 Nov; 154(3):370-5. PubMed ID: 19619666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Very low density lipoprotein receptor promotes adipocyte differentiation and mediates the proadipogenic effect of peroxisome proliferator-activated receptor gamma agonists.
    Tao H; Hajri T
    Biochem Pharmacol; 2011 Dec; 82(12):1950-62. PubMed ID: 21924248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of PPARdelta inhibits cardiac fibroblast proliferation and the transdifferentiation into myofibroblasts.
    Teunissen BE; Smeets PJ; Willemsen PH; De Windt LJ; Van der Vusse GJ; Van Bilsen M
    Cardiovasc Res; 2007 Aug; 75(3):519-29. PubMed ID: 17543901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PPARbeta/delta potentiates PPARgamma-stimulated adipocyte differentiation.
    Matsusue K; Peters JM; Gonzalez FJ
    FASEB J; 2004 Sep; 18(12):1477-9. PubMed ID: 15247146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnolol enhances adipocyte differentiation and glucose uptake in 3T3-L1 cells.
    Choi SS; Cha BY; Lee YS; Yonezawa T; Teruya T; Nagai K; Woo JT
    Life Sci; 2009 Jun; 84(25-26):908-14. PubMed ID: 19376135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stromelysin-3 is a potent negative regulator of adipogenesis participating to cancer cell-adipocyte interaction/crosstalk at the tumor invasive front.
    Andarawewa KL; Motrescu ER; Chenard MP; Gansmuller A; Stoll I; Tomasetto C; Rio MC
    Cancer Res; 2005 Dec; 65(23):10862-71. PubMed ID: 16322233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The peroxisome proliferator-activated receptor delta, an integrator of transcriptional repression and nuclear receptor signaling.
    Shi Y; Hon M; Evans RM
    Proc Natl Acad Sci U S A; 2002 Mar; 99(5):2613-8. PubMed ID: 11867749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome proliferator-activated receptor gamma ligands stimulate myeloid differentiation and lipogenensis in human leukemia NB4 cells.
    Yasugi E; Horiuchi A; Uemura I; Okuma E; Nakatsu M; Saeki K; Kamisaka Y; Kagechika H; Yasuda K; Yuo A
    Dev Growth Differ; 2006 Apr; 48(3):177-88. PubMed ID: 16573735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisome proliferator-activated receptor delta and gamma agonists differentially alter tumor differentiation and progression during mammary carcinogenesis.
    Yin Y; Russell RG; Dettin LE; Bai R; Wei ZL; Kozikowski AP; Kopelovich L; Glazer RI
    Cancer Res; 2005 May; 65(9):3950-7. PubMed ID: 15867396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxisome proliferator-activated receptor delta (PPARdelta) activation protects H9c2 cardiomyoblasts from oxidative stress-induced apoptosis.
    Pesant M; Sueur S; Dutartre P; Tallandier M; Grimaldi PA; Rochette L; Connat JL
    Cardiovasc Res; 2006 Feb; 69(2):440-9. PubMed ID: 16337160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pioglitazone and dexamethasone induce adipogenesis in D1 bone marrow stromal cell line, but not through the peroxisome proliferator-activated receptor-gamma pathway.
    Hung SH; Yeh CH; Huang HT; Wu P; Ho ML; Chen CH; Wang C; Chao D; Wang GJ
    Life Sci; 2008 Mar; 82(11-12):561-9. PubMed ID: 18272184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of peroxisome proliferator-activated receptor delta activity affects neural cell adhesion molecule and polysialyltransferase ST8SiaIV induction by teratogenic valproic acid analogs in F9 cell differentiation.
    Lampen A; Grimaldi PA; Nau H
    Mol Pharmacol; 2005 Jul; 68(1):193-203. PubMed ID: 15829700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide profiling of PPARgamma:RXR and RNA polymerase II occupancy reveals temporal activation of distinct metabolic pathways and changes in RXR dimer composition during adipogenesis.
    Nielsen R; Pedersen TA; Hagenbeek D; Moulos P; Siersbaek R; Megens E; Denissov S; Børgesen M; Francoijs KJ; Mandrup S; Stunnenberg HG
    Genes Dev; 2008 Nov; 22(21):2953-67. PubMed ID: 18981474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The peroxisome proliferator-activated receptor N-terminal domain controls isotype-selective gene expression and adipogenesis.
    Hummasti S; Tontonoz P
    Mol Endocrinol; 2006 Jun; 20(6):1261-75. PubMed ID: 16556736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-talk between vitamin D receptor (VDR)- and peroxisome proliferator-activated receptor (PPAR)-signaling in melanoma cells.
    Sertznig P; Dunlop T; Seifert M; Tilgen W; Reichrath J
    Anticancer Res; 2009 Sep; 29(9):3647-58. PubMed ID: 19667161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human placental peroxisome proliferator-activated receptor delta and gamma expression in healthy pregnancy and in preeclampsia and intrauterine growth restriction.
    Rodie VA; Young A; Jordan F; Sattar N; Greer IA; Freeman DJ
    J Soc Gynecol Investig; 2005 Jul; 12(5):320-9. PubMed ID: 15979543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PAR-1622 is a selective peroxisome proliferator-activated receptor gamma partial activator with preserved antidiabetic efficacy and broader safety profile for fluid retention.
    Kim MK; Chae YN; Kim HS; Choi SH; Son MH; Kim SH; Kim JK; Moon HS; Park SK; Shin YA; Kim JG; Lee CH; Lim JI; Shin CY
    Arch Pharm Res; 2009 May; 32(5):721-7. PubMed ID: 19471887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.